pantoprazole has been researched along with Adenocarcinoma in 9 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pantoprazole can alleviate cancer cachexia-induced body weight reduction and inhibit skeletal muscle wasting in a dose-dependent manner." | 7.85 | Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response. ( Guo, D; Qiao, Z; Tang, H; Wang, C; Wang, Q, 2017) |
| " The present study was conducted to explore the effect of pantoprazole on gastric adenocarcinoma through the regulation of Wnt/β-catenin signaling." | 7.79 | Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling. ( Chen, M; Guo, H; Huang, S; Liu, P; Shen, W; Shen, Y; Zhang, L; Zou, X, 2013) |
| "To investigate reversal effects of pantoprazole (PPZ) on multidrug resistance (MDR) in human gastric adenocarcinoma cells in vivo and in vitro." | 7.78 | Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. ( Chen, M; Huang, SL; Yang, VW; Zhang, B; Zhang, XQ; Zhu, H; Zou, XP, 2012) |
| "Pantoprazole can alleviate cancer cachexia-induced body weight reduction and inhibit skeletal muscle wasting in a dose-dependent manner." | 3.85 | Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response. ( Guo, D; Qiao, Z; Tang, H; Wang, C; Wang, Q, 2017) |
| " The present study was conducted to explore the effect of pantoprazole on gastric adenocarcinoma through the regulation of Wnt/β-catenin signaling." | 3.79 | Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling. ( Chen, M; Guo, H; Huang, S; Liu, P; Shen, W; Shen, Y; Zhang, L; Zou, X, 2013) |
| "To investigate reversal effects of pantoprazole (PPZ) on multidrug resistance (MDR) in human gastric adenocarcinoma cells in vivo and in vitro." | 3.78 | Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. ( Chen, M; Huang, SL; Yang, VW; Zhang, B; Zhang, XQ; Zhu, H; Zou, XP, 2012) |
| "We pretreated cell lines derived from human melanomas, adenocarcinomas, and lymphomas with the PPIs omeprazole, esomeprazole, or pantoprazole and tested their response to cytotoxic drugs in cell death assays." | 3.72 | Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. ( Arancia, G; Belardelli, F; De Milito, A; Fais, S; Federici, C; Iessi, E; Logozzi, M; Lozupone, F; Luciani, F; Lugini, L; Marra, M; Molinari, A; Montinaro, A; Parmiani, G; Rivoltini, L; Spada, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, T | 1 |
| Kim, KS | 1 |
| Na, K | 1 |
| Guo, D | 1 |
| Wang, C | 1 |
| Wang, Q | 1 |
| Qiao, Z | 1 |
| Tang, H | 1 |
| Arif, H | 1 |
| Suchniak-Mussari, K | 1 |
| Cothron, K | 1 |
| Toney, R | 1 |
| Shen, W | 2 |
| Zou, X | 2 |
| Chen, M | 3 |
| Shen, Y | 2 |
| Huang, S | 2 |
| Guo, H | 1 |
| Zhang, L | 2 |
| Liu, P | 1 |
| Oh, TH | 1 |
| Jung, HY | 1 |
| Choi, KD | 1 |
| Lee, GH | 1 |
| Song, HJ | 1 |
| Choi, KS | 1 |
| Chung, JW | 1 |
| Byeon, JS | 1 |
| Myung, SJ | 1 |
| Yang, SK | 1 |
| Kim, JH | 1 |
| Hu, YS | 1 |
| Feng, DK | 1 |
| Ying, WH | 1 |
| Wu, Y | 1 |
| Huang, SL | 1 |
| Zhang, XQ | 1 |
| Zhang, B | 1 |
| Zhu, H | 1 |
| Yang, VW | 1 |
| Zou, XP | 1 |
| Luciani, F | 1 |
| Spada, M | 1 |
| De Milito, A | 1 |
| Molinari, A | 1 |
| Rivoltini, L | 1 |
| Montinaro, A | 1 |
| Marra, M | 1 |
| Lugini, L | 1 |
| Logozzi, M | 1 |
| Lozupone, F | 1 |
| Federici, C | 1 |
| Iessi, E | 1 |
| Parmiani, G | 1 |
| Arancia, G | 1 |
| Belardelli, F | 1 |
| Fais, S | 1 |
9 other studies available for pantoprazole and Adenocarcinoma
| Article | Year |
|---|---|
Nanocracker capable of simultaneously reversing both P-glycoprotein and tumor microenvironment.
Topics: Adenocarcinoma; Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B; A | 2023 |
Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Apoptosis; Cachexia; Cell Prolifer | 2017 |
Duodenal Invasion of Pancreatic Cancer Resulting in Hematemesis.
Topics: Adenocarcinoma; Duodenum; Endoscopy, Digestive System; Female; Hematemesis; Humans; Middle Aged; Neo | 2019 |
Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Prolifera | 2013 |
Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Anti-Ulce | 2009 |
Pancreaticogastrostomy for high-risk gland after pancreaticoduodenectomy: an eligible choice?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Ampulla of Vater; Anastomosis, Surgical; Bi | 2011 |
Effects of pantoprazole as a HIF-1α inhibitor on human gastric adenocarcinoma sgc-7901 cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Anti-Ulcer Agents; Apoptosis; Blot | 2012 |
Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; ATP Binding | 2012 |
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; Benzimidazo | 2004 |